✦ LIBER ✦

Phase III studies in the therapy of small cell lung cancer (SCLC) : a North Central Cancer Treatment Group (NCCTG) trial

Book ID: 122717909
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 114 KB
Volume: 10
Category: Article
ISSN: 0169-5002
DOI: 10.1016/0169-5002(94)91711-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase III studies in the therapy of smal

Phase III studies in the therapy of small cell lung cancer (SCLC): A North Central Cancer Treatment Group (NCCTG) trial

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Pilot studies of the north central cance

Pilot studies of the north central cancer treatment group (NCCTG) utilizing accelerated hyperfractionated thoracic radiation therapy (AHTRT) in unresectable stage IIIA/B non-small cell lung cancer (NSCLC)

✍ Shaw, E; Jett, J; Brindle, J; McGinnis, W; Mailliard, J; Deming, R; Creagan, E; 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Alternating versus sequential chemo/radi

Alternating versus sequential chemo/radiotherapy in Small Cell Lung Cancer (SCLC). Phase III trial of the EORTC Lung Cancer Co-operative Group (08877)

✍ Gregor, A.; Drings, P.; Postmus, P.; Burghouts, JTM.; Evrard, D.; Kirkpatrick, A 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 77 KB

A randomized phase II trial of amonafide

A randomized phase II trial of amonafide or trimetrexate in patients with advanced non-small cell lung cancer. A trial of the north central cancer treatment group

✍ Dean H. Gesme Jr.; James R. Jett; Dennis D. Schreffler; John Q. Su; James A. Mai 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 376 KB 👁 2 views

Response rate and toxicity of pre-operat

Response rate and toxicity of pre-operative paclitaxel (P) and carboplatin (C) in patients with resectable non-small cell lung cancer: A North Central Cancer Treatment Group (NCCTG) Study

✍ Marks, R.S; Stella, P.J; Streitz, J.M; Mahoney, M.R; Deschamps, C 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 116 KB

Prognostic factors differ by tumor stage

Prognostic factors differ by tumor stage for small cell lung cancer : A pooled analysis of North Central Cancer Treatment Group trials

✍ Nathan R. Foster; Sumithra J. Mandrekar; Steven E. Schild; Garth D. Nelson; Kend 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 306 KB 👁 2 views

## Abstract ## BACKGROUND: An analysis of 14 small cell lung cancer (SCLC) trials was performed to improve the current understanding of potential prognostic factors for overall survival (OS) and progression‐free survival (PFS) in groups of patients with limited‐stage disease SCLC (LD‐SCLC) and ext